![Nairn McMaster](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Nairn McMaster is currently the Chief Commercial Officer at Sinclair Pharma Ltd.
He started this position in 2020.
Previously, he worked as the Commercial Director at IS Pharma Plc.
Postes actifs de Nairn McMaster
Sociétés | Poste | Début |
---|---|---|
SINCLAIR PHARMA PLC | Corporate Officer/Principal | 01/02/2019 |
Anciens postes connus de Nairn McMaster
Sociétés | Poste | Fin |
---|---|---|
IS Pharma Plc
![]() IS Pharma Plc Pharmaceuticals: MajorHealth Technology IS Pharma Plc engages in development and commercial exploitation of healthcare products. The company develops, acquires and commercializes late stage pharmaceuticals and medical devices, focusing in critical care, oncology and neurology. Its products are Aloxi, aquoral, ContiSol, Cryogesic, Dermogesic, episil, Micelle Nanotechnology, Mysoline, OptiFlo and Variquel/Haemopressin. The company is headquartered in Chester, the United Kingdom. | Corporate Officer/Principal | 08/10/2012 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
IS Pharma Plc
![]() IS Pharma Plc Pharmaceuticals: MajorHealth Technology IS Pharma Plc engages in development and commercial exploitation of healthcare products. The company develops, acquires and commercializes late stage pharmaceuticals and medical devices, focusing in critical care, oncology and neurology. Its products are Aloxi, aquoral, ContiSol, Cryogesic, Dermogesic, episil, Micelle Nanotechnology, Mysoline, OptiFlo and Variquel/Haemopressin. The company is headquartered in Chester, the United Kingdom. | Health Technology |
Sinclair Pharma Ltd.
![]() Sinclair Pharma Ltd. Medical SpecialtiesHealth Technology Sinclair Pharma Ltd. operates as an aesthetic dermatology company which provides solutions through collagen stimulation for facial volume loss, thread lifting for facial contouring, and dermal fillers for wrinkles and lines. It operates through the following business segments: Country Operations and International Operations. The Country Operations segment comprises the proprietary sales infrastructure from the operations in France, the United Kingdom, Italy, Germany, and Spain. The International Operations segment focuses on the sale through a local distributor. The company was founded in 1971 and is headquartered in London, the United Kingdom. | Health Technology |